SignalXSignalX

TWST Twist Bioscience Corp

Q4 2025 10-Q
Filed: Feb 2, 2026Period ending Dec 31, 2025
Health Care
Biological Products, (No Diagnostic Substances)SEC EDGAR
Twist Bioscience Corp Overview

Twist Bioscience Corp (TWST) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 2, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Risk Factors

  • • No material changes in risk factors from 10-K; risks primarily forward-looking statement disclaimers
  • • Regulatory risk: potential liability from undisclosed future acquisitions, mergers, or joint ventures
+3 more insights

Get deeper insights on Twist Bioscience Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.